{
    "nct_id": "NCT04715958",
    "official_title": "Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation",
    "inclusion_criteria": "* Provide signed and dated informed consent form\n* Willing to comply with all study procedures and be available for the duration of the study\n* At least 21 years old\n* Be diagnosed with breast cancer (T1 or greater LABC, any N and M0)\n* Be scheduled for neoadjuvant chemotherapy\n* Be medically stable\n* Be conscious and able to comply with study procedures\n* If a female of child-bearing potential, must have a negative urine pregnancy test\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Males\n* Females who are pregnant or nursing\n* Patients with other primary cancers requiring systemic treatment\n* Patients with any distal metastatic disease\n* Patients undergoing neoadjuvant endocrine therapy\n* Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example:\n\n  * Patients on life support or in a critical care unit;\n  * Patients with unstable occlusive disease (e.g., crescendo angina);\n  * Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia;\n  * Patients with uncontrolled congestive heart failure (New York Heart Association [NYHA] Class IV);\n  * Patients with recent cerebral hemorrhage;\n  * Patients who have undergone surgery within 24 hours prior to the study sonographic examination\n* Patients with known hypersensitivity or allergy to any component of Definity\n* Patients with unstable cardiopulmonary conditions or respiratory distress syndrome\n* Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli",
    "miscellaneous_criteria": ""
}